Laura Boos

952 total citations
15 papers, 272 citations indexed

About

Laura Boos is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Laura Boos has authored 15 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Laura Boos's work include Complement system in diseases (3 papers), Peripheral Neuropathies and Disorders (2 papers) and CAR-T cell therapy research (2 papers). Laura Boos is often cited by papers focused on Complement system in diseases (3 papers), Peripheral Neuropathies and Disorders (2 papers) and CAR-T cell therapy research (2 papers). Laura Boos collaborates with scholars based in Switzerland, United Kingdom and United States. Laura Boos's co-authors include Scott R. Barnum, Alexander J. Szalai, Robert S. Ames, Rick A. Wetsel, Iain L. Campbell, Anja Schmitt, Aurel Perren, Ilaria Marinoni, Matthias S. Dettmer and Samra Turajlic and has published in prestigious journals such as Cell, The Journal of Immunology and Annals of Oncology.

In The Last Decade

Laura Boos

14 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Laura Boos Switzerland	9	107	69	67	50	42	15	272
J Scott Sloka Canada	8	102 1.0×	30 0.4×	64 1.0×	52 1.0×	228 5.4×	11	383
Claudia Luther Germany	9	231 2.2×	29 0.4×	53 0.8×	88 1.8×	54 1.3×	10	405
Gordon Byrnes United States	8	44 0.4×	39 0.6×	38 0.6×	69 1.4×	53 1.3×	12	535
Norio Takayashiki Japan	9	37 0.3×	28 0.4×	79 1.2×	22 0.4×	20 0.5×	41	335
Sahl Khalid Bedri Sweden	7	30 0.3×	29 0.4×	25 0.4×	51 1.0×	41 1.0×	10	221
Ide Smets Belgium	10	98 0.9×	25 0.4×	41 0.6×	71 1.4×	134 3.2×	28	303
Weller United Kingdom	7	242 2.3×	35 0.5×	238 3.6×	35 0.7×	24 0.6×	8	432
Yoshimi Nakamura Japan	10	38 0.4×	30 0.4×	47 0.7×	61 1.2×	36 0.9×	39	364
Takeshi Kezuka Japan	14	111 1.0×	56 0.8×	42 0.6×	124 2.5×	153 3.6×	20	495
Valentina Bardina Italy	9	157 1.5×	20 0.3×	90 1.3×	41 0.8×	163 3.9×	15	416

Countries citing papers authored by Laura Boos

Since Specialization

Citations

This map shows the geographic impact of Laura Boos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Boos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Boos more than expected).

Fields of papers citing papers by Laura Boos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Boos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Boos. The network helps show where Laura Boos may publish in the future.

Co-authorship network of co-authors of Laura Boos

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Boos. A scholar is included among the top collaborators of Laura Boos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Boos. Laura Boos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Mehra, Tarun, Dominik Menges, Nicola Miglino, et al.. (2025). Comparative cost analysis of a diagnostic multi-omics platform for decision support in advanced cancer – results from the Tumor Profiler Melanoma project. npj Precision Oncology. 10(1). 35–35.

Schmid, Sabine, Sacha I. Rothschild, Laura Boos, et al.. (2024). Real-World Outcomes of Patients With Malignant Pleural Mesothelioma Receiving a Combination of Ipilimumab and Nivolumab as First- or Later-Line Treatment. JTO Clinical and Research Reports. 5(12). 100735–100735. 2 indexed citations

Boos, Laura & Andreas Wicki. (2024). The molecular tumor board—a key element of precision oncology. memo - Magazine of European Medical Oncology. 17(3). 190–193. 3 indexed citations

Schmid, Sabine, Sämi Schär, Oliver Gautschi, et al.. (2023). Patterns of progression on first line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study. Lung Cancer. 187. 107427–107427. 9 indexed citations

Schmid, Sabine, M. Frueh, Sacha I. Rothschild, et al.. (2023). 2191P Real-world outcomes of patients with malignant pleural mesothelioma (MPM) treated with combination nivolumab and ipilimumab in the first- or later line setting. Annals of Oncology. 34. S1133–S1134. 1 indexed citations

Au, Lewis, Laura Boos, Anthony J. Swerdlow, et al.. (2020). Cancer, COVID-19, and Antiviral Immunity: The CAPTURE Study. Cell. 183(1). 4–10. 22 indexed citations

Boos, Laura, Isla Leslie, & James Larkin. (2020). Metastatic melanoma: therapeutic agents in preclinical and early clinical development. Expert Opinion on Investigational Drugs. 29(7). 739–753. 3 indexed citations

Comito, Francesca, Isla Leslie, Laura Boos, et al.. (2020). Oligoprogression After Checkpoint Inhibition in Metastatic Melanoma Treated With Locoregional Therapy: A Single-center Retrospective Analysis. Journal of Immunotherapy. 43(8). 250–255. 8 indexed citations

Leslie, Isla, Laura Boos, James Larkin, & Lisa Pickering. (2020). Avelumab and axitinib in the treatment of renal cell carcinoma: safety and efficacy. Expert Review of Anticancer Therapy. 20(5). 343–354. 3 indexed citations

10.

Boos, Laura, Anja Schmitt, Holger Moch, et al.. (2019). MiRNAs Are Involved in Tall Cell Morphology in Papillary Thyroid Carcinoma. Cancers. 11(6). 885–885. 8 indexed citations

11.

Blank, Annika, Ilaria Marinoni, Laura Boos, et al.. (2015). Interlaboratory variability of MIB1 staining in well-differentiated pancreatic neuroendocrine tumors. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 467(5). 543–550. 24 indexed citations

12.

Boos, Laura, Matthias S. Dettmer, Anja Schmitt, et al.. (2013). Diagnostic and prognostic implications of the PAX8–PPARγ translocation in thyroid carcinomas—a TMA‐based study of 226 cases. Histopathology. 63(2). 234–241. 31 indexed citations

13.

Boos, Laura, Alexander J. Szalai, & Scott R. Barnum. (2005). C3a expressed in the central nervous system protects against LPS-induced shock. Neuroscience Letters. 387(2). 68–71. 46 indexed citations

14.

Boos, Laura, Alexander J. Szalai, & Scott R. Barnum. (2004). Murine complement C4 is not required for experimental autoimmune encephalomyelitis. Glia. 49(1). 158–160. 27 indexed citations

15.

Boos, Laura, Iain L. Campbell, Robert S. Ames, Rick A. Wetsel, & Scott R. Barnum. (2004). Deletion of the Complement Anaphylatoxin C3a Receptor Attenuates, Whereas Ectopic Expression of C3a in the Brain Exacerbates, Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 173(7). 4708–4714. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact